Conditions and Treatments
- Acute Lymphocytic Leukemia (ALL)
- Chronic Myelogenous Leukemia (CML)
- Myeloproliferative Neoplasms
Ratings and Reviews
4.961 Ratings 11 Comments |
|
---|---|
CP concern for questions/worries | 5.0 |
CP efforts to include in decisions | 4.9 |
CP explanations of prob/condition | 5.0 |
CP spoke using clear language | 5.0 |
Friendliness/courtesy of CP | 5.0 |
Likelihood of recommending CP | 5.0 |
Patients' confidence in CP | 5.0 |
Time CP spent with patient | 4.9 |
Wait time at clinic | 4.1 |
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Experience Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good.
Patient Comments
- December 4, 2020Absolutely fantastic, awesome great experience.
- October 29, 2020I really enjoyed meeting Dr. Pardee; he was professional, knowledgeable, attentive and informative. I greatly appreciate the time he and his fellow spent with me.
- October 26, 2020Excellent provider
- October 9, 2020Great experience.
- September 2, 2020Love Dr. Pardee
- August 31, 2020One great dr.
- August 4, 2020Doctor was knowledgeable & easy to talk to.
- July 21, 2020I have been very impressed with everyone I have encountered at WF Comprehensive Cancer Center.
- May 29, 2020I love Dr. Pardee ! He is probably the best doctor I have ever been to !
- April 21, 2020Great experience & care.
- March 31, 2020*Dr. Pardee and his team helped save my life when I had leukemia.
Locations
Credentials
Education
- PhD, University of Buffalo - State University of New York, 1999
- MD, University of Buffalo - State University of New York, 2003
Residency
- Internal Medicine, Massachusetts General Hospital, 2005
Fellowship
- Hematology And Oncology, Cold Spring Harbor Laboratory, 2006
- Hematology And Oncology, Stony Brook School of Medicine, 2009
Board Certifications
- American Board of Internal Medicine, Hematology
- American Board of Internal Medicine, Medical Oncology
Positions
- Physician
- Associate Professor, Hematology and Oncology
- Associate Professor, Cancer Biology
Insurance
Wake Forest Baptist accepts most major health insurance plans for hospital, physician and clinic services and participates in Medicare and Medicaid government programs. For more information, visit Billing and Insurance.
This chart is a list of the most common health insurance plans we accept. This list is subject to change. Please check your individual plan to confirm their participation and the coverage allowed.
Due to the different physician groups and hospitals within the Wake Forest Baptist system, physician services and hospital services are billed separately. Please remember that health insurance coverage varies, so some services may not be covered.
If you don’t see your plan or you have questions, please call our Customer Service Center at 877-938-7497. We will do our best to work with you and your plan.
Key
WFUHS - Wake Forest University Health Sciences (professional services)
NCBH - North Carolina Baptist Hospital
LMC - Lexington Medical Center
CHC - Cornerstone Healthcare
Wilkes - Wilkes Regional Medical Center
HPR- High Point Regional
N/A - Not applicable to services provided at facility and/or CHC
NC - Not Contracted, very low to no volume for facility and/or CHC
Wake Forest Baptist Health Managed Care/MA Contracts - January 2019
AETNA (PPO & HMO): Accepted at all locations
AETNA MEDICARE: Accepted at all locations
AETNA WHOLE HEALTH: Accepted at all locations
BCBSNC (PPO & HMO): Accepted at all locations
BLUE MEDICARE: Accepted at all locations
BLUE VALUE: Accepted at all locations
CAROLINA BEHAVIORAL HEALTH: Accepted at WFUHS, NCBH and CHC (not applicable to services provided at Davie, LMC, Wilkes and High Point)
CIGNA: Accepted at all locations
CIGNA BEHAVIORAL HEALTH: Accepted at NCBH and High Point (not applicable to services provided at Davie, LMC, CHC and Wilkes)
CIGNA HEALTHSPRING MEDICARE ADVANTAGE: Accepted at WFUHS, NCBH, Davie, LMC and CHC (not applicable to services provided at Wilkes and High Point)
CIGNA LIFESOURCE (TRANSPLANTS): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
COVENTRY/WELLPATH: Accepted at all locations
CRESCENT PPO (ASHEVILLE): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
DIRECT NET: Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
FIRST HEALTH (COVENTRY): Accepted at all locations
FIRSTCAROLINACARE (PINEHURST, NC): Accepted at NCBH (not contracted, very low to no volume for WFUHS, Davie, LMC, CHC, Wilkes and High Point)
GATEWAY HEALTH ALLIANCE (VIRGINIA): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
GOLDEN RULE INS (UNITED): Accepted at all locations
HEALTHGRAM (formerly PRIMARY PHYSICIAN CARE): Accepted at WFUHS, NCBH and LMC (not contracted, very low to no volume for Davie, CHC, Wilkes and High Point)
HEALTHTEAM ADVANTAGE: Accepted at all locations
HUMANA CHOICECARE: Accepted at all locations
HUMANA MEDICARE ADVANTAGE: Accepted at all locations
LIBERTY ADVANTAGE (MEDICARE ADVANTAGE): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
MAGELLAN (BEHAVIORAL HEALTH): Accepted at WFUHS, NCBH and CHC (not applicable to services provided at Davie, LMC, Wilkes and High Point)
MEDCOST: Accepted at all locations
MEDCOST ULTRA: Accepted at WFUHS, NCBH, Davie, LMC, Wilkes and High Point (not applicable at CHC)
OPTUMHEALTH (TRANSPLANTS - APPLICABLE TO NCBH/WFUHS ONLY): Accepted at WFUHS and NCBH (not applicable to services provided at Davie, LMC, CHC, Wilkes and High Point)
PREFERRED CARE OF VA INC: Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
SOUTHERN HEALTH SVCS (COVENTRY-PPO ONLY): Accepted at WFUHS, NCBH, Davie and CHC (not contracted, very low to no volume for LMC, Wilkes and High Point)
TWIN COUNTY (VIRGINIA): Accepted at WFUHS and NCBH (not contracted, very low to no volume for Davie, LMC, CHC, Wilkes and High Point)
UNITED BEHAVIORAL HEALTH: Accepted at WFUHS, NCBH, CHC and High Point (not applicable to services provided at Davie, LMC and Wilkes)
UNITED BEHAVIORAL HEALTH INTENSIVE OUTPATIENT PROGRAM (WFUHS ONLY): Accepted at WFUHS (not applicable for services provided at NCBH, Davie, LMC, CHC, Wilkes and High Point)
UNITED HEALTHCARE: Accepted at all locations
UNITED HEALTHCARE MEDICARE: Accepted at all locations
WELLPATH (COVENTRY): Accepted at all locations
LMC ONLY - Contracts specific to support Lexington employer groups, low volume
BEECHSTREET PPO
NATIONAL PROVIDER NETWORK/MEDICAL RESOURCES
PHCS/MULTIPLAN
CHC ONLY - contracts specific to support CHC
AETNA BEHAVIORAL HEALTH
CIGNA BEHAVIORAL HEALTH (limited providers)
THN-TRIAD HEALTH NETWORK MA Plans only (Humana Medicare and Healthteam Advantage)
TRICARE
Key
WFUHS - Wake Forest University Health Sciences (professional services)
NCBH - North Carolina Baptist Hospital
LMC - Lexington Medical Center
CHC - Cornerstone Healthcare
Wilkes - Wilkes Regional Medical Center
HPR- High Point Regional
N/A - Not applicable to services provided at facility and/or CHC
NC - Not Contracted, very low to no volume for facility and/or CHC
Research
- Inflammatory biomarkers, geriatric assessment, and treatment outcomes in acute myeloid leukemia. Loh KP, Tooze JA, Nicklas BJ, Kritchevsky SB, Williamson JD, Ellis LR, Powell BL, Pardee TS, Goyal NG, Klepin HD. J Geriatr Oncol. 2020 04; 11(3):410-416.
- Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity. Lin KH, Xie A, Rutter JC, Ahn YR, Lloyd-Cowden JM, Nichols AG, Soderquist RS, Koves TR, Muoio DM, MacIver NJ, Lamba JK, Pardee TS, McCall CM, Rizzieri DA, Wood KC. Cell Metab. 2019 05; 29(5):1217-1231.e7.
- Association between glycemic control, age, and outcomes among intensively treated patients with acute myeloid leukemia. Kuhlman P, Isom S, Pardee TS, Burns C, Tawfik B, Lamar ZS, Powell BL, Klepin HD. Support Care Cancer. 2019 Aug; 27(8):2877-2884.
- Mitochondria in cancer metabolism, an organelle whose time has come?. Anderson RG, Ghiraldeli LP, Pardee TS. Biochim Biophys Acta Rev Cancer. 2018 08; 1870(1):96-102.
- A Phase I Study of CPI-613 in Combination with High-Dose Cytarabine and Mitoxantrone for Relapsed or Refractory Acute Myeloid Leukemia. Pardee TS, Anderson RG, Pladna KM, Isom S, Ghiraldeli LP, Miller LD, Chou JW, Jin G, Zhang W, Ellis LR, Berenzon D, Howard DS, Hurd DD, Manuel M, Dralle S, Lyerly S, Powell BL. Clin. Cancer Res. 2018 05; 24(9):2060-2073.
- A Study of the Metabolic Changes in Leukemia Cells Following Treatment in Acute Myeloid Leukemia Patients
- A Study of Patients With Philadelphia Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia
- Study of the drug Uproleselan given with Chemotherapy versus Chemotherapy Alone in Patients with Relapsed/Refractory Acute Myeloid Leukemia